Security key
30049G302
Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK)
CUSIP: 30049G302
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,552,381
- Total 13F shares
- 232,022
- Share change
- -10,184
- Total reported value
- $603,642
- Price per share
- $2.60
- Number of holders
- 10
- Value change
- -$26,836
- Number of buys
- 3
- Number of sells
- 1
Report period
Q2 2025
Institutions
10
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 30049G302
Recent filing periods:
Top shareholders of EVOK - Evoke Pharma Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) as of Q2 2025
As of 30 Jun 2025,
Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
232,022 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Bleichroeder LP, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), FMR LLC, BlackRock, Inc., SBI Securities Co., Ltd., MORGAN STANLEY, NewEdge Advisors, LLC, and BANK OF AMERICA CORP /DE/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
9
Q2 2025 holders
10
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.